Caraco Seeks Supreme Court Intervention In Its Prandin Patent Use Code Battle With Novo
This article was originally published in The Pink Sheet Daily
Executive Summary
Caraco asks the Supreme Court to decide whether it can file a counterclaim opposing Novo's revision of its patent use code for the diabetes drug.